Elucidating Novel Immune and Genomic Markers for ALK (ENIGMA+)
ALK-positive lung cancer is a subtype of lung cancer which carries a genetic change involving a gene called ALK (anaplastic lymphoma kinase). About 5% of lung cancers are ALK-positive. In these ALK-positive lung cancers, the abnormal ALK protein tells the cancer to grow.
The purpose of this research study is to obtain and study the tissue and saliva specimens from patients with ALK-positive lung cancer, along with clinical information about their disease and treatment.
Click on topic below for more information.